We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IOVA market cap is 1.16B. The company's latest EPS is USD -1.1351 and P/E is -3.09.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 482k | 715k | 31.11M | 58.56M | 73.69M |
| Operating Income | -121.26M | -117.72M | -101.91M | -89.07M | -86.58M |
| Net Income | -116.38M | -112.98M | -97.1M | -83.54M | -78.56M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 1.19M | 164.07M |
| Operating Income | -261.94M | -342.7M | -398.88M | -460.56M | -395.28M |
| Net Income | -259.58M | -342.25M | -395.89M | -444.04M | -372.18M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 780.35M | 869.83M | 964.32M | 991.12M | 910.43M |
| Total Liabilities | 195.74M | 189.81M | 195.78M | 217.66M | 200.02M |
| Total Equity | 584.61M | 680.02M | 768.54M | 773.46M | 710.41M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 768.46M | 777.33M | 663.98M | 780.35M | 910.43M |
| Total Liabilities | 111.96M | 155.67M | 164.34M | 195.74M | 200.02M |
| Total Equity | 656.5M | 621.66M | 499.64M | 584.61M | 710.41M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -361.82M | -122.28M | -220.71M | -279.68M | -352.98M |
| Investing | -155.24M | -111.51M | -71.29M | -120.09M | -96.41M |
| Financing | 462.96M | 193.58M | 346.4M | 388.36M | 390.66M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -205.13M | -227.94M | -292.76M | -361.82M | -352.98M |
| Investing | -317.85M | 132k | 256.46M | -155.24M | -96.41M |
| Financing | 576.42M | 239.27M | 190.15M | 462.96M | 390.66M |
| Market Cap | 1.16B |
| Price to Earnings Ratio | -3.09 |
| Price to Sales Ratio | 7.01 |
| Price to Cash Ratio | 9.95 |
| Price to Book Ratio | 1.62 |
| Dividend Yield | - |
| Shares Outstanding | 327.88M |
| Average Volume (1 week) | 7.81M |
| Average Volume (1 Month) | 9.88M |
| 52 Week Change | -69.30% |
| 52 Week High | 14.23 |
| 52 Week Low | 2.70 |
| Spread (Intraday) | 0.04 (1.13%) |
| Company Name | Iovance Biotherapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.iovance.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
